177 related articles for article (PubMed ID: 36293074)
1. Blockade of Platelet CysLT1R Receptor with Zafirlukast Counteracts Platelet Protumoral Action and Prevents Breast Cancer Metastasis to Bone and Lung.
Saier L; Ribeiro J; Daunizeau T; Houssin A; Ichim G; Barette C; Bouazza L; Peyruchaud O
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293074
[TBL] [Abstract][Full Text] [Related]
2. Cysteinyl Leukotriene Pathway and Cancer.
Tsai MJ; Chang WA; Chuang CH; Wu KL; Cheng CH; Sheu CC; Hsu YL; Hung JY
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008546
[TBL] [Abstract][Full Text] [Related]
3. Cysteinyl leukotriene receptor type 1 (CysLT1R) antagonist zafirlukast protects against TNF-α-induced endothelial inflammation.
Zhou X; Cai J; Liu W; Wu X; Gao C
Biomed Pharmacother; 2019 Mar; 111():452-459. PubMed ID: 30594784
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions.
Wenzel J; Zeisig R; Fichtner I
Clin Exp Metastasis; 2010; 27(1):25-34. PubMed ID: 19916050
[TBL] [Abstract][Full Text] [Related]
5. CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer.
Savari S; Liu M; Zhang Y; Sime W; Sjölander A
PLoS One; 2013; 8(9):e73466. PubMed ID: 24039952
[TBL] [Abstract][Full Text] [Related]
6. Cysteinyl leukotriene receptor 1 promotes 5-fluorouracil resistance and resistance-derived stemness in colon cancer cells.
Satapathy SR; Sjölander A
Cancer Lett; 2020 Sep; 488():50-62. PubMed ID: 32474153
[TBL] [Abstract][Full Text] [Related]
7. Allergen challenge-induced changes in bone-marrow responses to leukotriene D
Masid-de-Brito D; Vieira BM; de Souza CC; Silva F; Gaspar-Elsas MIC; Xavier-Elsas P
Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):199-210. PubMed ID: 32122206
[No Abstract] [Full Text] [Related]
8. Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.
Gareau AJ; Brien C; Gebremeskel S; Liwski RS; Johnston B; Bezuhly M
Clin Exp Metastasis; 2018 Feb; 35(1-2):25-35. PubMed ID: 29322294
[TBL] [Abstract][Full Text] [Related]
9. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production.
Doherty TA; Khorram N; Lund S; Mehta AK; Croft M; Broide DH
J Allergy Clin Immunol; 2013 Jul; 132(1):205-13. PubMed ID: 23688412
[TBL] [Abstract][Full Text] [Related]
10. CysLT
Ghosh A; Chen F; Wu F; Tang SS; Hu M; Long Y; Sun HB; Kong LY; Hong H
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Feb; 73():19-30. PubMed ID: 27720931
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice.
Lev DC; Kim SJ; Onn A; Stone V; Nam DH; Yazici S; Fidler IJ; Price JE
Clin Cancer Res; 2005 Jan; 11(1):306-14. PubMed ID: 15671560
[TBL] [Abstract][Full Text] [Related]
12. Cysteinyl leukotriene receptor 1 regulates glucose-stimulated insulin secretion (GSIS).
Guo R; Jiang J; Jing Z; Chen Y; Shi Z; Deng B
Cell Signal; 2018 Jun; 46():129-134. PubMed ID: 29412178
[TBL] [Abstract][Full Text] [Related]
13. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.
David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O
PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819
[TBL] [Abstract][Full Text] [Related]
14. Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1.
Biagioli M; Carino A; Marchianò S; Roselli R; Di Giorgio C; Bordoni M; Fiorucci C; Sepe V; Conflitti P; Limongelli V; Distrutti E; Baldoni M; Zampella A; Fiorucci S
Biochem Pharmacol; 2020 Jul; 177():113987. PubMed ID: 32330496
[TBL] [Abstract][Full Text] [Related]
15. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
[TBL] [Abstract][Full Text] [Related]
16. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling.
Lai J; Mei ZL; Wang H; Hu M; Long Y; Miao MX; Li N; Hong H
Neurochem Int; 2014 Sep; 75():26-31. PubMed ID: 24879954
[TBL] [Abstract][Full Text] [Related]
17. Zafirlukast: the first leukotriene-receptor antagonist approved for the treatment of asthma.
Kelloway JS
Ann Pharmacother; 1997 Sep; 31(9):1012-21. PubMed ID: 9296243
[TBL] [Abstract][Full Text] [Related]
18. Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis.
Zovko A; Yektaei-Karin E; Salamon D; Nilsson A; Wallvik J; Stenke L
Oncol Rep; 2018 Aug; 40(2):902-908. PubMed ID: 29845257
[TBL] [Abstract][Full Text] [Related]
19. Summary of clinical trials with zafirlukast.
Calhoun WJ
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S238-45; discussion S245-8. PubMed ID: 9647606
[TBL] [Abstract][Full Text] [Related]
20. Zafirlukast is a broad-spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times.
Holbrook LM; Keeton SJ; Sasikumar P; Nock S; Gelzinis J; Brunt E; Ryan S; Pantos MM; Verbetsky CA; Gibbins JM; Kennedy DR
Br J Pharmacol; 2021 Feb; 178(3):550-563. PubMed ID: 33080041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
